Table 2.
The antimicrobial resistance profiling of 21 carbapenem-resistant HMKP isolates.
Antimicrobials | HMKP (n = 21) | |
---|---|---|
No. | % | |
Amikacin | 16 | 76.2 |
Ampicillin | 21 | 100.0 |
Amicillin/sulbatam | 21 | 100.0 |
Aztreonam | 21 | 100.0 |
Cefazolin | 21 | 100.0 |
Cefotetan | 19 | 90.5 |
Ceftriaxone | 21 | 100.0 |
Cefepime | 17 | 80.9 |
Ceftazidime | 19 | 90.5 |
Ceftriaxone | 21 | 100.0 |
Ciprofloxacin | 17 | 80.9 |
Colistin | 0 | 0 |
Imipenem | 21 | 100.0 |
Levofloxacin | 17 | 80.9 |
Fosfomycin | 15 | 71.4 |
TZPa | 21 | 100.0 |
Tobramycin | 17 | 80.9 |
Gentamicin | 17 | 80.9 |
SXTb | 1 | 4.8 |
TZP, Piperacillin/tazobactam.
SXT, trimethoprim/sulfamethoxazole.